VTRS
Viatris Wins FDA Approval for Gwyn Lo Contraceptive Patch
Viatris Inc. (Nasdaq: VTRS) announced on July 29 that the FDA has approved Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system), a new once-weekly contraceptive patch delivering a lower dose of estrogen than some existing patch options. The approval covers women with a body mass index below 30 kg/m squared who are appropriate candidates for…
